Sarepta Therapeutics | SRPT - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Capricor Therapeutics USD 59K 0 2025-12
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
Eli Lilly USD 21.18B 1.02B 2026-03
Gilead Sciences USD 5.06B 314M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.19B 19M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06